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INTRODUCTION
Although several novel diagnostic tests for tuberculosis
infection have been developed and commercially licensed in
recent years, the tuberculin skin test (TST) is still widely
used for identifying latent tuberculosis infection (LTBI). Sev-
eral difficulties exist, however, in the application and inter-
pretation of the TST. For example, the reaction may be accen-
tuated on repeated test, which can cause the test to be mis-
interpreted as a skin test conversion (1). The prevalence of
boosted reaction is generally correlated with the prevalence
of initial tuberculin reactions and is particularly common in
individuals who have been vaccinated with bacille Calmette-
Guerin (BCG) (1-4). Therefore, an evaluation of the preva-
lence of boosted reaction and the associated factors would be
important for the assessment of TST reactivity in countries
that have a high prevalence of tuberculosis (TB) and a rou-
tine BCG vaccination policy (3, 5-7). However, no publish-
ed data exist on the boosted reaction in an adult South Kore-
an population, which has an intermediate incidence of TB
(96 cases per 100,000 population per year) (8) and a nation-
al policy of mass BCG vaccination. 
The objectives of this study were to estimate the rate of
boosted reaction and to evaluate the associated factors among
military personnel in a setting with an intermediate burden
of TB and routine BCG vaccination policy.
MATERIALS AND METHODS
Some South Korean troops, mostly engineers, have been
operating in Afghanistan on a 6-month rotation since 2002
to help with the reconstruction effort in that war-torn coun-
try. As part of the TB control program of the Armed Forces
Medical Command, Republic of Korea, the troops dispatch-
ed to Afghanistan, which have shown a high incidence of
TB (168 cases per 100,000 population per year) (8), have
undergone screening tests for TB in addition to a medical
examination before and after deployment at the Armed Forces
Capital Hospital since 2006. 
We performed two-step TSTs on the troops that were to
be dispatched to Afghanistan for 6-month missions as des-
cribed above in August 2006 with the approval of the ethics
committee of the Armed Forces Medical Command and after
obtaining informed consent from each subject. Before the
skin tests were performed, the troops completed question-
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Boosted Reaction on Two-Step Tuberculin Skin Test among 
Military Personnel in South Korea, a Setting with an Intermediate
Burden of Tuberculosis and Routine Bacille Calmette-Guerin Vaccination
This study was performed to estimate the rate of boosted reaction in the two-step
tuberculin skin test (TST) and to evaluate the associated factors among military per-
sonnel of South Korea, which has an intermediate burden of tuberculosis (TB) and
a routine bacille Calmette-Guerin (BCG) vaccination policy. Two-step TST was
performed on 264 military personnel who did not have a history of close contact to
TB. Subjects with a negative reaction to the first test of <10 mm had a second TST
applied 1 week later on the other forearm. A positive result (≥ ≥10 mm) on the initial
TST was observed in 126 (48%) of the subjects. A boosted reaction on the second
TST developed in 32 (23%) of the 124 subjects with a negative initial TST. In mul-
tiple logistic regression analysis, the size of the initial TST reaction was the only
factor associated with a boosted reaction on the second TST. The high rate of boost-
ed reaction among healthy adults in South Korea suggests that two-step TST should
be performed to assess the baseline TST reactivity in settings with an intermediate
burden of TB and routine BCG vaccination policy, especially among subjects with
an initial TST reaction that is ≥ ≥5 mm. 
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naires about previous TSTs, potential exposure to TB, treat-
ment for TB, and other demographic data. Subjects were
excluded from this study if they had a documented history
of TB or a history of close contact to TB. Because the records
of previous BCG vaccination were not available for most
subjects, the presence of a typical BCG scar was accepted to
indicate previous BCG vaccination (9). 
Tuberculin testing
TSTs were administered by injecting 0.1 mL of 2 tuber-
culin units of purified protein derivative (RT 23; Statens
Serum Institute, Copenhagen, Denmark) into the anterior
surface of the forearm with disposable syringes and 27-gauge
needles using the intradermal Mantoux method. Reactions
were read 48-72 hr after the injection by a trained nurse, and
the largest transverse diameter of palpable induration was
recorded in millimeters. At the time of reading, the nurse
was unaware of each subject’s BCG vaccination status. A
positive TST result was defined as an induration of 10 mm
or more in diameter. Subjects with a reaction of <10 mm to
the first test had a second TST applied 1 week later on the
other forearm. The techniques for testing and reading were
the same as for the initial TST. A boosted reaction was defined
as a reaction of ≥10 mm on the second TST with a ≥6 mm
increase than on the first TST result (4).
Statistical analysis
Data were analyzed using SPSS 12.0 (SPSS Inc, Chicago,
IL, U.S.A.). To evaluate possible association between boost-
ing reaction and variables, odds ratio with 95% confidence
intervals (95% CI) were calculated. The likelihood ratio test
was used to assess the significance of this association. Then,
multiple logistic regression analysis was used to determine
the independent factors associated with boosting reaction.
RESULTS
In total, 264 troops were recruited to have a medical exam-
ination during the study period. Of these troops, 126 (48%)
had a positive result on the initial TST and were excluded
from further testing. Of the remaining 138 subjects with a
negative initial TST (≤9 mm), 14 subjects refused the sec-
ond TST and were excluded. The characteristics of the remain-
ing 124 (47%) subjects are presented in Table 1. The sub-
jects ranged in age from 20 to 47 yr, with a median age of
22 yr, and all of the subjects were male. None of the subjects
had a previous history of TST. Abnormal findings were not
observed on chest radiography or in the other laboratory tests
performed for the medical examination. A BCG scar was
present in 112 subjects (90%), and boosted reaction was
observed in 32 (23%) subjects. As shown in Table 2, boost-
BCG, bacille Calmete-Guerin.
Characteristics No. of subjects (%)
Age group
20-29 yr 110 (88.7)
30-39 yr 12 (9.7)
40-49 yr 2 (1.6)
BCG scar
Absent 12 (9.7)
Present 112 (90.3)
Size of the initial TST
0 mm 42 (33.9)
1-4 mm 24 (19.3)
5-9 mm 58 (46.8)
Table 1. Characteristics of the study subjects who received a
two-step tuberculin skin test (TST)
OR, odds ratio; CI, confidence interval; BCG, bacille Calmete-Guerin.
Associated factors Adjusted OR (95% CI)
Age (yr)
20-29 1.00
30-39 1.29 (0.33-5.12)
40-49 1.46 (0.09-24.80)
BCG scar
Absent 1.00
Present 2.10 (0.41-10.74)
Initial TST reaction (mm)
0 1.00
1-4 3.48 (0.85-14.16)
5-9 6.25 (1.93-20.29)
Table 3. Factors associated with the boosting reaction on sec-
ond tuberculin skin test (TST) by multiple logistic regression
analysis
OR, odds ratio; CI, confidence interval; BCG, bacille Calmete-Guerin.
*Likelihood ratio test was used to assess the significance of associations.
Absence of 
boosting 
reaction, 
No. (%)
(n=92)
Presence of
boosting
reaction, 
No. (%)
(n=32)
OR 
(95% CI)
p
value*
Age group 0.618
20-29 yr 83 (90.2) 27 (84.1) 1.00
30-39 yr 8 (8.7) 4 (12.5) 1.54 (0.43-5.51)
40-49 yr 1 (1.1) 1 (3.1) 3.07 (0.19-50.84)
BCG scar 0.427
Absent 10 (10.9) 2 (6.3) 1.00
Present 82 (89.1) 30 (93.8) 1.83 (0.38-8.83)
Initial TST reaction 0.004
0 mm 38 (41.3) 4 (12.5) 1.00
1-4 mm 18 (19.6) 6 (18.8) 3.17 (0.79-12.64)
5-9 mm 36 (39.1) 22 (68.8) 5.81 (1.82-18.50)
Table 2. Associations with boosting reaction on second tuber-
culin skin test (TST)404 K. Jeon, S.-H. Ji, S.-Y. Oh, et al.
ed reaction was not associated with increasing age or the pres-
ence of a BCG scar (p=0.618 and 0.427, respectively). The
size of the initial TST reaction was significantly associated
with boosted reaction (p=0.004). In multiple logistic regres-
sion analysis, the size of the initial TST reaction was the only
factor associated with boosted reaction on the second TST
(Table 3).
DISCUSSION
In the present study of the TST reactivity in Korean mili-
tary personnel, boosted reaction on the second TST devel-
oped in 23% of the subjects with a negative reaction on the
initial TST and was associated with the size of the initial TST
reaction. 
The definitions of a boosted reaction have differed in pre-
vious studies, and the rates of boosted reactions for two-step
TSTs have ranged from 0 to 59% (5-7, 10-19). The varia-
tion in the rates of boosted reactions among the different
studies reflects differences in the populations studied regard-
ing age, BCG vaccination status, and previous exposure to
TB or nontuberculous mycobacteria. Therefore, our finding
was expected to be similar to a study performed in Turkey,
which is characterized by an intermediate incidence of TB
and a routine BCG vaccination program as in South Korea;
that study found high positive rates of boosted reactions
(21%) (6). Even though the majority of our subjects were
younger than 30 yr (89%), our rate of boosted reactions was
11-17% higher than the rates reported by two other studies
performed in countries with a high prevalence of TB and
routine BCG vaccination (5, 7). This difference might be
attributable to the different proportions of males, who are
reportedly more likely to be positive of boosted reaction
(11, 20). 
Previous BCG vaccination has been reported to be one of
the most influential factors for boosted reaction (10, 12, 13,
16, 19, 20). In the present study, however, the presence of a
BCG scar was not associated with an increased rate of boost-
ed reaction. The lack of a BCG effect in our subjects could
have occurred because most BCG vaccinations in Korea are
performed during infancy; the prevalence of a BCG scar in
infants was approximately 88% during the seventh nation-
wide TB prevalence survey in Korea (21). Menzies et al. (12)
reported that BCG vaccination received in infancy has little
effect on the boosted reaction. In addition, previous studies
have documented a relationship between increasing age and
boosted reaction (5, 11-13); therefore, it is likely that we did
not observe a statistically significant relationship because of
the small number of older subjects in our study population.
The prevalence of an initial TST reaction has been correlat-
ed with the prevalence of the boosted reaction (12, 22, 23).
We found that the rate of positive boosted reaction as the
size of the initial TST reaction increased. Menzies et al. (12)
reported a frequency of boosted reactions of 3.7, 17.1, and
28.4% in subjects whose initial TST reactions measured 0,
1-4, and 5-9 mm, respectively. Alvarez et al. (22) found that
the rate of boosted reactions was 12.7 and 35.5% in subjects
with an initial reaction measuring 0-4 and 5-9 mm, respec-
tively. In the present study, the rates of boosted reactions
were 10, 25, and 38% in subjects with an initial TST reac-
tion measuring 0, 1-4, and 5-9 mm, respectively (p=0.004),
and the size of the initial TST reaction was the only factor
associated with boosted reaction on the second TST in mul-
tiple logistic regression analysis. 
Health care workers are at high risk for TB, and screening
of health care workers for TB is an important component of
infection control programs (1). However, little is known
about the TST reactivity in an adult South Korean popula-
tion. This is the first study to report the boosted reaction in
an adult South Korean population. Therefore, our results
suggest that the boosted reaction on repeated test should be
considered when TB screening of health care workers, who
are likely to receive periodic retesting, would be performed
hereafter in South Korea.
In conclusion, the prevalence of boosted reaction on repeat-
ed TST was high among adults in a setting with an inter-
mediate burden of TB and routine BCG vaccination policy,
and the size of the initial TST reaction was the only associ-
ated factor on multiple logistic regression analysis. There-
fore, to avoid misinterpreting the boosted reaction on sub-
sequent TST as a conversion, the use of a two-step TST would
be necessary to assess the baseline TST reactivity among sub-
jects with a negative reaction on initial TST, especially when
the size of the initial TST is >5 mm.
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